Arrhythmias, CardiacNCT00921986
Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
An observational study of Arrhythmias, Cardiac, run by The Cleveland Clinic at 1 site in United States.
Trial summary
Biorepository of blood and or tissue samples from patients presenting with cardiac arrhythmia syndromes. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Arrhythmias, Cardiac
- How many people
- 2,000 participants
- Where
- 1 siteUnited States
- Study dates
- Mar 2009to Dec 2035
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients undergoing arrhythmia procedures, cardiac surgery or inpatient or outpatient evaluations for arrhythmias at the Cleveland Clinic or from outside collaborative institutions or from other clinical trials.
Who may be able to join
- Male or female at least 18 years old
- Subjects with a history of or current cardiac arrhythmia, family members of subjects with cardiac arrhythmias, or no cardiac arrhythmia if a Control Subject.
Who cannot join
- Subjects previously enrolled in the Arrhythmia BioBank
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Cleveland Clinic Foundation
Cleveland, Ohio, 44195
Mina K. Chung, MD
David R. Van Wagoner, Ph.D.
About this study
Official title: Cleveland Clinic Arrhythmia Biospecimen Repository (Cleveland Clinic Arrhythmia BioBank)
Biorepository of blood and or tissue samples from patients presenting with cardiac arrhythmia syndromes.
Read the detailed description
The long-term objective of this research is to find genes and biologic pathways causing arrhythmia syndromes and other diseases or conditions. In order to achieve this objective the investigators will collect comprehensive phenotypic data and corresponding blood and/or tissue samples into a biorepository registry of patients, presenting for cardiac arrhythmia evaluation and/or treatment, and control subjects without arrhythmias. This biorepository will be composed of two parts: 1) An Arrhythmia Biorepository of blood and tissue from patients undergoing arrhythmia procedures, cardiac surgery, or inpatient or outpatient evaluations for arrhythmias, and 2) A Collaborative Sample Biorepository for de-identified samples and data from outside institutions and clinical trials.
- Conditions
- Arrhythmias, Cardiac
- Keywords
- genetics, biorepository, cardiac death, atrial fibrillation, ventricular fibrillation, ventricular tachycardia, supraventricular tachycardias, premature ventricular complexes, premature atrial complexes, atrioventricular and intraventricular blocks, sinus node dysfunction, syncope, vasovagal reactivity, postural orthostatic tachycardia syndrome
- Medical subject headings
- Arrhythmias, Cardiac, Death, Atrial Fibrillation, Ventricular Fibrillation, Tachycardia, Ventricular, Tachycardia, Supraventricular, Ventricular Premature Complexes, Atrial Premature Complexes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Arrhythmias | Patients with arrhythmias | |
| Control Subjects | Subjects that do not have a history of cardiac arrhythmias. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Genetic variants associated with arrhythmias
Genome-wide association study of arrhythmias
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jun 2009 (estimated)
- Study startMar 2009
- Primary completionDec 2035 (estimated)
- Study completionDec 2035 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Arrhythmias, CardiacStudies of the same condition, open and under way.
- More trials run by The Cleveland ClinicThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 2,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The Cleveland Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mina Chung, MD, The Cleveland Clinic
- Investigators
- Mina K. Chung, MD, Principal investigator, The Cleveland Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00921986
- Sponsor's protocol ID
- 09-176
- Status last verified
- Sep 2026
- First submitted
- 15 Jun 2009
- Last updated
- 14 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No